第一批能活到1000岁的人已出生？Neuralink联创抛出惊人预言

Core Viewpoint - The article discusses the advancements in brain-computer interface (BCI) technology, highlighting its potential to reshape human capabilities and even extend human life, as suggested by Max Hodak, co-founder of Neuralink and founder of Science [2][4]. Group 1: Brain-Computer Interface Technology - BCI technology has made significant breakthroughs, such as restoring vision for blind patients through retinal implants [9][12]. - Hodak emphasizes that the human brain functions similarly to a computer, processing information through neural pathways, which can be viewed as APIs for interaction with external systems [5][39]. - The potential applications of BCI range from restoring lost sensory functions to enhancing cognitive abilities and even preserving human consciousness [12][18]. Group 2: Clinical Applications and Innovations - Science, Hodak's company, has successfully conducted clinical trials that restored partial vision to over 40 patients using a small silicon chip implanted in the eye [14][15]. - The device operates by using a camera and laser projection to stimulate retinal cells, effectively bypassing damaged photoreceptors [15][26]. - Future developments may lead to higher bandwidth interfaces that allow for more complex interactions between the brain and digital systems [20][32]. Group 3: Future of BCI and Human Evolution - Hodak predicts that BCI technology will evolve to allow for direct brain-to-brain communication and enhanced human capabilities, potentially leading to a new paradigm in medicine and human enhancement [12][36]. - The integration of biological and engineering systems may result in a hybrid human form, where damaged organs are replaced with mechanical or electronic systems [12][62]. - The next generation of BCI may involve growing new neural connections rather than using electrical stimulation, which could lead to more natural and effective interfaces [62][64]. Group 4: Industry Insights and Comparisons - The BCI industry is compared to the pharmaceutical industry, suggesting that multiple companies will develop various types of interfaces tailored for specific applications [20][80]. - Hodak notes that the current BCI technology is still in its infancy, akin to the early days of personal computing, and emphasizes the need for continued innovation and belief in the technology's potential [60][62]. - The article highlights the shift in focus from traditional drug discovery to direct brain interaction, marking a significant change in medical paradigms [34][36].